Are Vraylar and Rexulti the Same Thing?
Vraylar (cariprazine) and Rexulti (brexpiprazole) are atypical antipsychotics used to treat schizophrenia.
Vraylar is also used for the acute treatment of manic or mixed episodes associated with bipolar I disorder.
Rexulti is also used as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD).
Side effects of Vraylar and Rexulti that are similar include extrapyramidal symptoms (muscle spasms, muscle rigidity, tremor, jerking movements), agitation, restlessness, weight gain, headache, constipation, anxiety, and dizziness.
Side effects of Vraylar that are different from Rexulti include indigestion, nausea, vomiting, sleepiness, insomnia, abdominal pain, toothache, diarrhea, pain in extremities, dry mouth, loss of appetite, back pain, and cough.
Side effects of Rexulti that are different from Vraylar include distress, fatigue, runny or stuffy nose, increased appetite, and drowsiness. Children, teenagers, and young adults may have suicidal thoughts while taking Rexulti. Tell your doctor if this occurs.
Both Vraylar and Rexulti may interact with CYP3A4 inducers (such as rifampin carbamazepine) and inhibitors (such as itraconazole and ketoconazole).
Rexulti may also interact with CYP2D6 inhibitors (such as paroxetine, fluoxetine, and quinidine).
What Are Possible Side Effects of Vraylar?
Side effects of Vraylar include:
- extrapyramidal symptoms (muscle spasms, muscle rigidity, tremor, jerking movements),
- weight gain,
- abdominal pain,
- pain in the extremities,
- dry mouth,
- loss of appetite,
- back pain,
- dizziness, and
What Are Possible Side Effects of Rexulti?
Common side effects of Rexulti include:
- weight gain,
- runny or stuffy nose,
- increased appetite,
- dizziness, and
- Children, teenagers, and young adults may have suicidal thoughts while taking Rexulti. Tell your doctor if this occurs.
This is not a complete list of side effects, and others may occur.
What Is Vraylar?
Vraylar (cariprazine) is an atypical antipsychotic indicated for the treatment of schizophrenia, and the acute treatment of manic or mixed episodes associated with bipolar I disorder.
What Is Rexulti?
Rexulti (brexpiprazole) is an atypical antipsychotic indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) and for treatment of schizophrenia.
What Drugs Interact With Vraylar?
Vraylar may interact with CYP3A4 inducers and inhibitors. Tell your doctor all medications and supplements you use.
What Drugs Interact With Rexulti?
Rexulti may interact with strong/moderate CYP2D6 or CYP3A4 inhibitors or strong CYP3A4 inducers. Tell your doctor all medications and supplements you use. The effects of Rexulti on a fetus are unknown. Neonates whose mothers are exposed to antipsychotic drugs, like Rexulti, during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms. There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to Rexulti during pregnancy. It is unknown if Rexulti passes into breast milk or if it would affect a nursing infant. Consult your doctor before breastfeeding.
How Should Vraylar Be Taken?
The starting dose of Vraylar is 1.5 mg once daily.
How Should Rexulti Be Taken?
The recommended starting dosage for Rexulti as adjunctive treatment for MDD is 0.5 mg or 1 mg once daily, taken orally. The recommended target Rexulti dosage to treat schizophrenia is 2 mg to 4 mg once daily.
Mental Health Resources
Health Solutions From Our Sponsors
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
Allergan. Vraylar Drug Information.
Osuka America Pharmaceutical. Rexulti Drug Information.